Psoriasis
Conditions
Brief summary
The primary objective of this study is to validate a dermatology-specific questionnaire that assesses patient satisfaction with their treatments across various inflammatory dermatology diseases.
Interventions
OTHERDermatology-Specific Treatment Satisfaction Instrument
Study subjects will also be administered a dermatology-specific treatment satisfaction questionnaire, as well as other questionnaires including the generic validated Treatment Satisfaction Questionnaire for Medication (TSQM-9) and the validated Dermatology Life Quality Index (DLQI). Study participants will also self-report their disease severity using PGA. Depending on patients' preferred method of interacting with the study team, the investigators will collect their responses to these questionnaires either in-person, over the phone, or electronically via secure research platforms.
Sponsors
Icahn School of Medicine at Mount Sinai
Brigham and Women's Hospital
University of Southern California
Study design
Observational model
COHORT
Time perspective
PROSPECTIVE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Adult (≥ 18 years) * Psoriasis patients undergoing some form of treatment
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Validity and reliability of a dermatology-specific treatment satisfaction instrument in patients with psoriasis | 8 months | For this survey study, the investigators will gather descriptive statistics for each item in the questionnaire. The investigators will also measure the following psychometric properties: measurement error, reliability and construct validity, as measured by convergent and known-groups validity |
Countries
United States
Outcome results
None listed